Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control
Vallejo-Vaz, Antonio J., Ray, Kausik K., Ginsberg, Henry N., Davidson, Michael H., Eckel, Robert H., Veronica Lee, L., Bessac, Laurence, Pordy, Robert, Letierce, Alexia, Cannon, Christopher P.Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2019.07.008
Date:
July, 2019
File:
PDF, 1.87 MB
english, 2019